Recently approved treatments for generalized myasthenia gravis (gMG), including complement and neonatal Fc receptor (FcRn) ...

Sugammadex (Bridion; Merck) is a small-molecule oligosaccharide, also known as a modified gamma cyclodextin, that was ...

Opens in a new tab or window Recently approved treatments for generalized myasthenia gravis (gMG), including ... but because different patients have medical comorbidities, socioeconomic factors ...

Myasthenia gravis (MG) should be classified according to antibody status (acetylcholine, MuSK, LRP4, titin), thymus (hyperplasia, neoplasia, atrophy), age at debut (< or >50 years), symptom ...

A clinical diagnosis of myasthenia gravis ... the disease to thymectomy. The hematologic changes recorded in this patient are atypical for systemic lupus erythematosus and may have represented ...

Myasthenia gravis (MG) should be subgrouped into early ... until all major symptoms are in a stable remission. Early thymectomy is recommended for early-onset, generalized MG with thymic ...

Thus, it appears that a departure in either direction from eumetabolic levels may be detrimental in myasthenia gravis. It is well known that any form of stress may have a nonspecific adverse ...

You have antibodies for AChR ... the researchers measured the effect of Vyvgart using a test called the Myasthenia Gravis-Specific Activities of Daily Living scale (MG-ADL), which shows how ...

president and chief executive of the Myasthenia Gravis Foundation of America. “This is an important development for the community because with more FDA-approved [therapies…] physicians have ...